eliglustat Articles
Sanofi buys Colombian drugmaker; Presents encouraging eliglustat and Lyxumia data; Revizes deal with B-MS
3 October 2012
Positive Ph II results for Genzyme’s oral Gaucher drug
9 February 2012
Strong Ph II data for Genzyme’s second Gaucher drug eliglustat
21 February 2011
Phase II study of Genzyme’s oral Gaucher's disease drug eliglustat yields positive results
5 May 2010
Showing 1-5 of 5 articles
- 1
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
